Company intelligence / Profile preview

Menssana Research

Newark, New Jersey, United Statesmenssanaresearch.co.uk ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Menssana Research has developed highly sensitive breath analysis devices that detect volatile organic compounds as biomarkers for various diseases. Their systems have CE Mark approval in the EU and are undergoing large-scale clinical validation studies in the US and internationally. Published data support their use in detecting breast cancer, lung cancer, tuberculosis, heart transplant rejection risk, and radiation response.

Therapeutic areas: OncologyPulmonologyImmunologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Metabolite Diagnostics

Partnerships

NIH/NIAID/BARDA funding partners for clinical studies

Beyond the preview

Go deeper on Menssana Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Menssana Research.

Explore the full profile